Lind Global Fund III LP

Holdings History for Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN)

Symbol: SLXN on Nasdaq
Investment type: Equity / Ordinary shares, par value $0.0135 per share
Latest Disclosed Shares Owned: 212,500 shares
Security Ownership %: 6.4%

Lind Global Fund III LP ownership in Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN)

14 Nov 2025 - Lind Global Fund III LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 212,500 shares of Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN). This represents 6.4% ownership of the company. In their previous filing dated 18 Sep 2025, Lind Global Fund III LP had reported owning 224,050 shares, indicating a decrease of +5.2%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Lind Global Fund III LP	6.4%	-35%	$187,000	212,500	-11,550	-5.2%	$0.88	13G/A	30 Sep 2025	14 Nov 2025, 16:09
Lind Global Fund III LP	9.9%		$197,164	224,050			$0.88	13G	12 Sep 2025	18 Sep 2025, 17:47